Mostrando ítems 1-4 de 4
Comajoan von Arend, Pau (Fecha de defensa: 2019-12-18)
Recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for the treatment of acute ischaemic stroke. However, the application of this therapy is limited to <5-7% of patients due to the ...
Puig Parnau, Irene (Fecha de defensa: 2021-06-01)
Electrical stimulation of deep brain areas has been suggested as a novel approach to restore memory circuits in Alzheimer’s disease (AD). Previous studies from our group have demonstrated that rewarding stimulation of the ...
Madruga Parera, Marc (Fecha de defensa: 2020-06-03)
The asymmetries detected in the different multi-directional sports vary in magnitude depending on the test selected. Furthermore, in the individual analysis of the different tests administered, it was observed that athlete’s ...
Muñoz San Martín, María (Fecha de defensa: 2021-09-15)
Multiple sclerosis (MS) is considered a chronic inflammatory and neurodegenerative disease, characterized by the existence of demyelinated areas in the central nervous system, infiltration of inflammatory cells in the ...